These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7966623)

  • 21. Viral transduction of c-myc gene in naturally occurring feline leukaemias.
    Mullins JI; Brody DS; Binari RC; Cotter SM
    Nature; 1984 Apr 26-May 2; 308(5962):856-8. PubMed ID: 6325922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas.
    Sheets RL; Pandey R; Jen WC; Roy-Burman P
    J Virol; 1993 Jun; 67(6):3118-25. PubMed ID: 8388492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma.
    Fujino Y; Liao CP; Zhao YS; Pan J; Mathes LE; Hayes KA; Ohno K; Tsujimoto H; Roy-Burman P
    Virology; 2009 Mar; 386(1):16-22. PubMed ID: 19203775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas.
    Dolcetti R; Rizzo S; Viel A; Maestro R; De Re V; Feriotto G; Boiocchi M
    Oncogene; 1989 Aug; 4(8):1009-14. PubMed ID: 2548143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral DNA--the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats.
    Nesina S; Katrin Helfer-Hungerbuehler A; Riond B; Boretti FS; Willi B; Meli ML; Grest P; Hofmann-Lehmann R
    Retrovirology; 2015 Dec; 12():105. PubMed ID: 26689419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral genetic variation, AIDS, and the multistep nature of carcinogenesis: the feline leukemia virus model.
    Rohn JL; Gwynn SR; Lauring AS; Linenberger ML; Overbaugh J
    Leukemia; 1996 Dec; 10(12):1867-9. PubMed ID: 8946923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection for c-myc integration sites in polyclonal T-cell lymphomas.
    Broussard DR; Mertz JA; Lozano M; Dudley JP
    J Virol; 2002 Mar; 76(5):2087-99. PubMed ID: 11836386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene.
    Stewart M; MacKay N; Cameron ER; Neil JC
    J Virol; 2002 May; 76(9):4364-9. PubMed ID: 11932403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
    Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
    Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells.
    Bonham L; Lobelle-Rich PA; Henderson LA; Levy LS
    J Virol; 1987 Oct; 61(10):3072-81. PubMed ID: 3041029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas.
    Lazo PA; Lee JS; Tsichlis PN
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):170-3. PubMed ID: 1688653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
    Bolin LL; Ahmad S; Lobelle-Rich PA; Ooms TG; Alvarez-Hernandez X; Didier PJ; Levy LS
    J Virol; 2013 Oct; 87(19):10874-83. PubMed ID: 23903838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurring proviral integration suggests a role for proto-oncogene activation in thymomas induced with Mo-MuLV-rescued BCR/ABL virus.
    Clark SS
    Leukemia; 1997 Jul; 11(7):1026-33. PubMed ID: 9204986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
    Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R
    Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feline leukemia virus variants in experimentally induced thymic lymphosarcomas.
    Pandey R; Bechtel MK; Su Y; Ghosh AK; Hayes KA; Mathes LE; Roy-Burman P
    Virology; 1995 Dec; 214(2):584-92. PubMed ID: 8553560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymerase chain reaction-based detection of myc transduction in feline leukemia virus-infected cats.
    Sumi R; Miyake A; Endo T; Ohsato Y; Ngo MH; Nishigaki K
    Arch Virol; 2018 Apr; 163(4):1073-1077. PubMed ID: 29353423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
    Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC
    Int J Cancer; 1993 Apr; 53(6):1023-30. PubMed ID: 8473043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C; Coan PN; Levy LS
    J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperating events in lymphomagenesis mediated by feline leukemia virus.
    Levy LS; Starkey CR; Prabhu S; Lobelle-Rich PA
    Leukemia; 1997 Apr; 11 Suppl 3():239-41. PubMed ID: 9209353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
    Schmidt T; Zörnig M; Beneke R; Möröy T
    Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.